Stock Earnings

Question 1

What are Centessa Pharmaceuticals PLC's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Centessa Pharmaceuticals PLC has a total asset of $576, Net loss of $-235

Question 2

What are the key financial ratios for CNTA?

Accepted Answer

Centessa Pharmaceuticals PLC's Current ratio is 3.29, has a Net margin is 0, sales per share of $0.

Question 3

How is Centessa Pharmaceuticals PLC's revenue broken down by segment or geography?

Accepted Answer

Centessa Pharmaceuticals PLC largest revenue segment is Pharmaceutical, at a revenue of 6,853,000 in the most earnings release.For geography, United Kingdom is the primary market for Centessa Pharmaceuticals PLC, at a revenue of 6,853,000.

Question 4

Is Centessa Pharmaceuticals PLC profitable?

Accepted Answer

no, according to the latest financial statements, Centessa Pharmaceuticals PLC has a net loss of $-235

Question 5

Does Centessa Pharmaceuticals PLC have any liabilities?

Accepted Answer

yes, Centessa Pharmaceuticals PLC has liability of 175

Question 6

How many outstanding shares for Centessa Pharmaceuticals PLC?

Accepted Answer

Centessa Pharmaceuticals PLC has a total outstanding shares of 132.63

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15	0	6	0	0	0
Revenue Growth (YoY)	150%	-100%	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	50	50	53	55	42	1
Research & Development	178	150	124	155	95	9
Operating Expenses	262	201	178	212	153	10
Other Non Operating Income (Expenses)	-1	-1	-5	2	-5	0
Pretax Income	-239	-232	-176	-216	-380	-10
Income Tax Expense	3	2	-25	0	0	--
Net Income	-242	-235	-151	-216	-381	-10
Net Income Growth	50%	56%	-30%	-43%	3,710%	100%
Shares Outstanding (Diluted)	134.16	114.47	96.17	93.4	75.17	87.42
Shares Change (YoY)	16%	19%	3%	24%	-14%	0%
EPS (Diluted)	-1.82	-2.05	-1.57	-2.31	-5.07	-0.12
EPS Growth	31%	31%	-32%	-54%	4,125%	100%
Free Cash Flow	-181	-142	-160	-201	-135	-10
Free Cash Flow Per Share	-1.34	-1.24	-1.66	-2.15	-1.79	-0.11
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,646.66%	0%	-2,850%	0%	0%	0%
Profit Margin	-1,613.33%	0%	-2,516.66%	0%	0%	0%
Free Cash Flow Margin	-1,206.66%	0%	-2,666.66%	0%	0%	0%
EBITDA	-247	-201	-171	-212	-153	-10
EBITDA Margin	-1,646.66%	0%	-2,850%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-247	-201	-171	-212	-153	-10
EBIT Margin	-1,646.66%	0%	-2,850%	0%	0%	0%
Effective Tax Rate	-1.25%	-0.86%	14.2%	0%	0%	--

Centessa Pharmaceuticals PLC (CNTA) Price

CNTA Stock Price Chart

CNTA Income

Follow-Up Questions